Current approaches with the glutamatergic system as targets in the treatment of neuropathic pain.
about
High-affinity glutamate transporters in chronic pain: an emerging therapeutic targetPharmacokinetics and pharmacodynamics of the glutamate carboxypeptidase II inhibitor 2-MPPA show prolonged alleviation of neuropathic pain through an indirect mechanism.β-Cyclodextrin-complexed (-)-linalool produces antinociceptive effect superior to that of (-)-linalool in experimental pain protocols.Ceftriaxone, a beta-lactam antibiotic, modulates apoptosis pathways and oxidative stress in a rat model of neuropathic pain.
P2860
Current approaches with the glutamatergic system as targets in the treatment of neuropathic pain.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Current approaches with the gl ...... treatment of neuropathic pain.
@en
Current approaches with the gl ...... treatment of neuropathic pain.
@nl
type
label
Current approaches with the gl ...... treatment of neuropathic pain.
@en
Current approaches with the gl ...... treatment of neuropathic pain.
@nl
prefLabel
Current approaches with the gl ...... treatment of neuropathic pain.
@en
Current approaches with the gl ...... treatment of neuropathic pain.
@nl
P2093
P2860
P1476
Current approaches with the gl ...... treatment of neuropathic pain.
@en
P2093
Arvind Semwal
Dharmarajan Sriram
Perumal Yogeeswari
Ramkumar Mishra
P2860
P304
P356
10.1517/14728220903029210
P407
P577
2009-08-01T00:00:00Z